Evidence map›Paper›PMID 24218169›Full record

ArticleCirculation research2014

Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.

Robert N Correll, Petra Eder, Adam R Burr, Sanda Despa, Jennifer Davis, Donald M Bers, Jeffery D Molkentin

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 67 citations in OpenAlex.

  1. Role of NaInternational journal of molecular sciences · 2024
    Review
  2. Sensational site: the sodium pump ouabain-binding site and its ligands.American journal of physiology. Cell physiology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The NaFrontiers in endocrinology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Cardiomyocyte NaAmerican journal of physiology. Heart and circulatory physiology · 2021
    Article
  14. Review
  15. The heart in hypertension.Journal of human hypertension · 2021
    Article
  16. The αScientific reports · 2020
    Article
  17. Article
  18. Stimulation of NaOxidative medicine and cellular longevity · 2019
    Article
  19. Role of the βMolecular and cellular biochemistry · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Robert N Correll *Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Petra Eder *Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Adam R BurrDepartment of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Sanda DespaDepartment of Pharmacology, UC Davis, Davis, California, USA.
Jennifer DavisDepartment of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Donald M BersDepartment of Pharmacology, UC Davis, Davis, California, USA.
Jeffery D MolkentinDepartment of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Howard Hughes Medical Institute · US

Funding

Program AdministrationP01HL080101 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2006 to 2015
$23.4M
PKCa Signaling Regulates Contractility and Heart FailureP50HL077101 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 2005 to 2009
$19.1M
PKC alpha as a translational target in Heart FailureP01HL108806 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI RABINOWITZ, JOSEPH E · 2012 to 2016
$11.3M
VENTRICULAR MYOSIN LIGHT CHAIN 2 FUNCTION IN NORMAL AND FAILING HEARTSP50HL052318 · NHLBI · UNIVERSITY OF CINCINNATI · PI DORN, GERALD W. · 1995 to 2004
$8.8M
Thrombospondin 4 regulates adaptive ER stress responseRenewal - Resubmission - 1R01HL105924 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Jeffery D Molkentin · 2011 to 2026
$7.3M
Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
Phospholemman and Na-Pump Function in Cardiac MyocytesR01HL081562 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2005 to 2018
$5.3M
IONIC CONTROL OF CARDIAC MUSCLE CONTRACTION: EC COUPLINGR37HL030077 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2005 to 2014
$3.9M
Molecular Pathways Controlling Cardiac Gene ExpressionR37HL060562 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MOLKENTIN, JEFFERY D · 2008 to 2017
$3.8M
MBNL1's function in myofibroblast transformation and fibrosisR00HL119353 · NHLBI · UNIVERSITY OF WASHINGTON · PI DAVIS, JENNIFER MICHELLE · 2015 to 2017
$747k
MBNL1's function in myofibroblast transformation and fibrosisK99HL119353 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI DAVIS, JENNIFER MICHELLE · 2013 to 2014
$262k
Regulation of Cardiac Gene Expression by the L-type Calcium Channel, CaV1.2.F32HL097551 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CORRELL, ROBERT NATHAN · 2009 to 2011
$117k
NHLBI NIH HHS F32 HL097551NHLBI NIH HHS F32HL097551NHLBI NIH HHS K99 HL119353NHLBI NIH HHS P01 HL080101NHLBI NIH HHS P01 HL108806NHLBI NIH HHS P50 HL052318NHLBI NIH HHS P50 HL077101NHLBI NIH HHS R00 HL119353NHLBI NIH HHS R01 HL081562NHLBI NIH HHS R01 HL105924NHLBI NIH HHS R37 HL030077NHLBI NIH HHS R37 HL060562NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

rationaleThe Na+ / K+ ATPase (NKA) directly regulates intracellular Na+ levels, which in turn indirectly regulates Ca2+ levels by proximally controlling flux through the Na+ / Ca2+ exchanger (NCX1). Elevated Na+ levels have been reported during heart failure, which permits some degree of reverse-mode Ca2+ entry through NCX1, as well as less efficient Ca2+ clearance.

objectiveTo determine whether maintaining lower intracellular Na+ levels by NKA overexpression in the heart would enhance forward-mode Ca2+ clearance and prevent reverse-mode Ca2+ entry through NCX1 to protect the heart. METHODS AND

resultsCardiac-specific transgenic mice overexpressing either NKA-α1 or NKA-α2 were generated and subjected to pressure overload hypertrophic stimulation. We found that although increased expression of NKA-α1 had no protective effect, overexpression of NKA-α2 significantly decreased cardiac hypertrophy after pressure overload in mice at 2, 10, and 16 weeks of stimulation. Remarkably, total NKA protein expression and activity were not altered in either of these 2 transgenic models because increased expression of one isoform led to a concomitant decrease in the other endogenous isoform. NKA-α2 overexpression but not NKA-α1 led to significantly faster removal of bulk Ca2+ from the cytosol in a manner requiring NCX1 activity. Mechanistically, overexpressed NKA-α2 showed greater affinity for Na+ compared with NKA-α1, leading to more efficient clearance of this ion. Furthermore, overexpression of NKA-α2 but not NKA-α1 was coupled to a decrease in phospholemman expression and phosphorylation, which would favor greater NKA activity, NCX1 activity, and Ca2+ removal.

conclusionsOur results suggest that the protective effect produced by increased expression of NKA-α2 on the heart after pressure overload is due to more efficient Ca2+ clearance because this isoform of NKA preferentially enhances NCX1 activity compared with NKA-α1.

Indexed as

Ventricular RemodelingAnimalsCalciumCalcium-Binding ProteinsCardiomegalyCells, CulturedDisease Models, AnimalIsoenzymesMiceMice, TransgenicMyocardiumPhospholambanPhosphorylationRatsSodiumSodium-Calcium ExchangerAtp1a1 protein, ratAtp1a2 protein, ratCalciumCalcium-Binding ProteinsIsoenzymesNCX1 protein, mousePhospholambanSodiumSodium-Calcium Exchangersodium-calcium exchanger 1Sodium-Potassium-Exchanging ATPasecalcium signalinghypertrophymyocardial contractionmyocytes, cardiacsodium

Identifiers

PMID24218169
PMCPMC4001807
OpenAlexW2156908692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.